THANK YOU TO OUR SHM
CONVERGE 2026 SPONSORS!
SPONSORED EVENTS
EXPERT THEATER
FOCUSING ON THE FRONT
LINE OF HEPATORENAL
SYNDROME—ACUTE KIDNEY
INJURY (HRS-AKI) RECOGNITION
AND REVERSAL
MARCH 30, 2026
12:30 - 1:30 P.M.
EXPERT THEATER 1
The Focusing on the Front Line of Hepatorenal Syndrome–Acute Kidney Injury (HRS-AKI) Recognition and Reversal Expert Theater will highlight the importance of early recognition and current diagnosis and treatment recommendations for hepatorenal syndrome–acute kidney injury (HRS-AKI).
Sponsored by: Keenova
EXPERT THEATER
SCALING AI IN HOSPITAL
MEDICINE: LESSONS FROM
HOUSTON METHODIST’S JOURNEY
MARCH 30, 2026
12:30 - 1:30 P.M.
EXPERT THEATER 3
Houston Methodist’s System CMIO and Chief Health AI Officer, Dr. Jordan Dale, will share how a leading academic health system is thoughtfully integrating AI into hospital medicine. From ambient documentation to emerging clinical intelligence capabilities, this conversation will explore what is working, evolving, and how to responsibly scale AI across hospitalist teams.
Attendees will gain practical insights into:
- Driving adoption among hospitalists in acute care settings
- Embedding AI into existing EHR workflows
- Measuring value
- Laying the groundwork for broader clinical guidance and operational impact
This session will examine the real-world operational considerations behind building an AI-enabled inpatient care setting.
Sponsored by: Ambience
EXPERT THEATER
THE ROLE OF TECHNOLOGY IN
HOSPITAL MEDICINE: THE CASE
FOR IMPROVING REVENUE BY
IMPROVING CARE
MARCH 31, 2026
12:30 - 1:30 P.M.
EXPERT THEATER 2
Technology investment in health systems flows overwhelmingly to revenue cycle. Getting resources for tools that actually benefit clinicians and patients requires a different kind of business case. Dr. David Kirk, CMO at Regard, leads a panel with hospital medicine leaders from Banner Health and CommonSpirit Health on how they’ve navigated the push and pull of technology investment — and turned that argument into action.
Sponsored by: Regard
SITUATION ROOM
COVID-19: FROM SYMPTOMS
TO SOLUTIONS
MARCH 31, 2026
9:45 - 10:45 A.M.
ROOM 209C
Join Pfizer to connect with fellow hospitalists committed to optimizing COVID-19 management. Following a brief overview of emerging trends, participate in a collaborative scenario-based discussion addressing clinical challenges led by expert facilitators. Review approaches to treating mild-to-moderate cases. Leave with practical strategies to advance care and improve patient outcomes.
Sponsored by: Pfizer
SITUATION ROOM
ANTICOAGULATION
MANAGEMENT IN PATIENTS
WITH NVAF/VTE
MARCH 31, 2026
11:45 A.M. - 1:00 P.M.
ROOM 209C
Join Bristol Myers Squibb-Pfizer Alliance for a unique, interactive peer-to-peer learning opportunity and discussion. The small group discussions will include practice sharing and review of various clinical scenarios with the objective of supporting clinicians in reviewing strategies for anticoagulation management in patients with NVAF/VTE.
Sponsored by: Bristol Myers Squibb-Pfizer Alliance
POP-UP EVENT
A-CUTE CAFE
MARCH 30, 2026
8:45 A.M. - 4:45 P.M.
BOOTH #613
EXHIBIT HALL,
ENTRANCE IN HALL A1
Sponsored by: Ambience
CHAPTER LEADER EVENT
CHAPTER LEADER
NETWORKING EVENT
MARCH 29, 2026
4:00 - 5:00 P.M.
ROOM 105 A-B
Chapter Leaders, join your fellow SHM Chapter Leaders and District Chairs immediately following the Chapter Leader Training at Converge for a networking session at the Music City Center.
Keep the conversation going by connecting with new peers, sharing key takeaways from the training, and building meaningful relationships across the SHM community.
Supported by: Boehringer Ingelheim
EXPERT THEATER
KERENDIA (FINERENONE):
A CORE PILLAR OF
COMPREHENSIVE CARE FOR
YOUR INPATIENTS WITH HEART
FAILURE LVEF (HF LVEF) ≥40%
MARCH 30, 2026
12:30 - 1:30 P.M.
EXPERT THEATER 2
This hospitalist-focused program examines patients hospitalized with heart failure and left ventricular ejection fraction (LVEF) ≥40%, highlighting the high risk of HF readmissions, CV mortality, and healthcare costs in this population. The presentation reviews the role of guideline-directed medical therapy during hospitalization, emphasizing initiation and optimization of evidence-based therapies prior to discharge. Using data from the FINEARTS-HF trial, the program will explore how initiation of KERENDIA can reduce the risk of hospitalization for HF, urgent HF visits, and CV death. Case-based discussion will illustrate practical inpatient use, dosing considerations, safety and hyperkalemia monitoring, and care-transition planning, positioning KERENDIA as a core pillar of inpatient management for appropriate HF LVEF ≥40% patients.
Sponsored by: Bayer
EXPERT THEATER
AN ORAL THERAPY FOR
TREATING MODERATE-TO-
SEVERE ACUTE PAIN
MARCH 31, 2026
12:30 - 1:30 P.M.
EXPERT THEATER 1
Join Vertex Pharmaceuticals for an expert-led discussion of moderate-to-severe acute pain in adults. Explore unmet needs, discuss clinical trial results for an oral therapy, and review considerations for formulary decision-makers.
Sponsored by: Vertex Pharmaceuticals
SATELLITE SYMPOSIUM
IMPROVING ACCESS TO
PARENTERAL NUTRITION (PN) IN
THE HOSPITAL: WHAT THE
HOSPITALIST NEEDS TO KNOW
ABOUT SUPPLEMENTAL PN,
LIPIDS, AND SAFE USE
MARCH 30, 2026
8:45 - 9:45 A.M.
ROOM 103 A-C
Join for a full breakfast and session that explores innovations and safety strategies in parenteral nutrition, emphasizing the clinical role of alternative lipid sources. Speakers will share actionable strategies and best practices for the use of alternative lipids in nutrition, PN’s place in clinical therapy, and best practices for multi-chamber bag PN. Presented by Institute for Safe Medication Practices (ISMP) www.ismp.org. View the full agenda here.
Sponsored by: Institute for Safe Medication Practices
SATELLITE SYMPOSIUM
SECONDARY STROKE
PREVENTION TODAY AND
TOMORROW: WHERE EVOLVING
ANTITHROMBOTIC STRATEGIES
MAY FIT INTO HOSPITALIST CARE
MARCH 31, 2026
11:20 A.M. - 12:20 P.M.
ROOM 103 A-C
Answers in CME (AiCME) is an independent medical education provider dedicated to delivering succinct, short-format educational activities that connect healthcare professionals with dynamic clinical content. We leverage cognitive learning principles and innovative instructional techniques to present science in a manner that is engaging, informative, and impactful. Our aim is to be a trusted provider of high-quality, evidence-based continuing medical educational activities that help healthcare professionals to stay current with the latest advances in their fields and improve their skills.
At AiCME, we are committed to enhancing the learning experience and improving the quality of education across various therapeutic areas through microburst learning platforms using proprietary technologies. By narrowing the knowledge gap and increasing clinician competence, our CME program supports practice improvements that help patients live longer, healthier, better-quality lives.
AiCME is pleased to hold accreditations from both the Accreditation Council for Continuing Medical Education (ACCME) and the European Board for Accreditation of Continuing Education for Health Professionals (EBAC). Additionally, we are proud to be a member organization of the Good CME Practice Group (gCMEp).
Sponsored by: Answers in CME and Bayer
POP-UP EVENT
RIV Reception Drink Tickets
MARCH 30, 2026
8:45 A.M. - 4:45 P.M.
BOOTH #613, BOOTH #541,
BOOTH #333, BOOTH #239
EXHIBIT HALL,
ENTRANCE IN HALL A1
Sponsored by: Auburn University, BMJ Group, Claimocity, and Enjoin
